Recent advances in policy and practice translation of the evidence for additional omega-3 fatty acids and prematurity

Curr Opin Clin Nutr Metab Care. 2022 Mar 1;25(2):81-85. doi: 10.1097/MCO.0000000000000806.

Abstract

Purpose of review: This is a review of the most up-to-date research on the effectiveness of omega-3 fatty acids for reducing the risk of prematurity in well nourished women with access to high-quality obstetric care. It will provide an overview of the translation of the evidence on omega-3 screening into policy, and the latest research on how to implement the policy into practice.

Recent findings: Findings of the included clinical studies support that omega-3 supplementation for women with a singleton pregnancy who have a low omega-3 status reduces the risk of early preterm birth.

Summary: There is evidence that screening and providing appropriate advice to women with a singleton pregnancy who have a low omega-3 status can reduce their risk of early preterm birth, and avoiding supplementation for women who are replete will avoid unnecessary supplementation and potential harm.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dietary Supplements
  • Fatty Acids, Omega-3* / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Policy
  • Pregnancy
  • Premature Birth* / prevention & control

Substances

  • Fatty Acids, Omega-3